December 20, 2022

From the Co-Chairs, December 2022

Reflections on NCI-MATCH and its successor trials; research results in leukemia and breast cancer; and grant renewal preparations
December 20, 2022

Re-Opened Trial: EA9152 for T-cell or B-cell Acute Lymphoblastic Leukemia

This study is investigating the safety and efficacy of venetoclax, a BCL-2 inhibitor, in combination with vincristine sulfate in the relapsed or refractory ALL population
December 20, 2022

Remembering Jerome C. Landry, MD, MBA

In July, the field of radiation oncology lost an expert and pioneer
December 20, 2022

Remembering Edward G. Mansour, MD

In November, the field of breast cancer research lost a revolutionary
December 20, 2022

A General Session to Remember: NCI Director Monica Bertagnolli Delivers First Public Speech, ECOG-ACRIN Honors Two Esteemed Colleagues

Some of the most memorable moments of the 10th Anniversary General Session featured three individuals who have been key participants and collaborators in ECOG-ACRIN’s research over the years
December 20, 2022

36 Member Networks and Programs Receive Commendations in 2022 for Outstanding Research Performance

In an annual evaluation, 36 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
December 20, 2022

Aurora NCORP Pilots Natural Language Processing Tool to Find Patients with Pancreatic Cysts for EA2185

Funding and support are now available to sites to implement natural language processing for recruitment of patients to study EA2185
December 20, 2022

Trial Spotlight: Robert Ferris on the EA3132 Trial for Patients with Head and Neck Cancer

This phase 2 study is examining whether the addition of cisplatin to PORT will provide a survival benefit to certain patients with stage 3/4 squamous cell carcinoma of the head and neck
December 20, 2022

News in Brief, December 2022

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more